NL8702598A - Immunoregulator die een estradiolderivaat bevat. - Google Patents

Immunoregulator die een estradiolderivaat bevat. Download PDF

Info

Publication number
NL8702598A
NL8702598A NL8702598A NL8702598A NL8702598A NL 8702598 A NL8702598 A NL 8702598A NL 8702598 A NL8702598 A NL 8702598A NL 8702598 A NL8702598 A NL 8702598A NL 8702598 A NL8702598 A NL 8702598A
Authority
NL
Netherlands
Prior art keywords
weight
substance
parts
estradiol
present
Prior art date
Application number
NL8702598A
Other languages
English (en)
Dutch (nl)
Original Assignee
Kureha Chemical Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Chemical Ind Co Ltd filed Critical Kureha Chemical Ind Co Ltd
Publication of NL8702598A publication Critical patent/NL8702598A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NL8702598A 1986-11-12 1987-10-30 Immunoregulator die een estradiolderivaat bevat. NL8702598A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26894086 1986-11-12
JP61268940A JPH0621072B2 (ja) 1986-11-12 1986-11-12 エストラジオ−ル誘導体よりなる免疫調節剤

Publications (1)

Publication Number Publication Date
NL8702598A true NL8702598A (nl) 1988-06-01

Family

ID=17465393

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8702598A NL8702598A (nl) 1986-11-12 1987-10-30 Immunoregulator die een estradiolderivaat bevat.

Country Status (9)

Country Link
US (1) US4885290A (fr)
JP (1) JPH0621072B2 (fr)
AT (1) AT393222B (fr)
AU (1) AU585179B2 (fr)
CH (1) CH674465A5 (fr)
DE (1) DE3736691A1 (fr)
GB (2) GB2197588B (fr)
IT (1) IT1223323B (fr)
NL (1) NL8702598A (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0794377B2 (ja) * 1987-07-22 1995-10-11 呉羽化学工業株式会社 エストラジオール誘導体を含有する注射剤
CA1335792C (fr) * 1987-08-18 1995-06-06 Chaim O. Jacob Methode et forme posologique utilisant un antagoniste de l'interferon gamma pour lutter contre les maladies auto-immunes associees au cmh
JPH04356428A (ja) * 1991-02-26 1992-12-10 Keisuke Hirasawa 免疫抑制剤
JP2520074B2 (ja) * 1992-06-11 1996-07-31 呉羽化学工業株式会社 新規なエストラジオ―ル誘導体−クロラムブチル結合体、その製造方法、及び医薬製剤
US5494899A (en) * 1993-04-07 1996-02-27 Oklahoma Medical Research Foundation Selective regulation of B lymphocyte precursors by hormones
JPH07101977A (ja) * 1993-10-05 1995-04-18 Kureha Chem Ind Co Ltd ホルモン作用を軽減した新規なエストラジオール誘導体及びその増殖因子阻害剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1175468A (en) * 1967-10-19 1969-12-23 Merck Ag E Pharmaceutical Compositions
US4029778A (en) * 1969-01-23 1977-06-14 Aktiebolaget Leo Cortical steroid nitrogen mustard compositions and treatment therewith
GB1558472A (en) * 1976-01-22 1980-01-03 Leo Ab 17-esters of 17- hydroxy gestogens
GB1527161A (en) * 1976-02-19 1978-10-04 Leo A Enol esters of steroids
US4096254A (en) * 1976-05-10 1978-06-20 Richardson-Merrell Inc. Method of treating the symptoms of menopause and osteoporosis
JPS5822120B2 (ja) * 1978-03-31 1983-05-06 大塚製薬株式会社 ３−０−（β−Ｄ−グルクロノピラノシル）−ソ−ヤサポゲノ−ルＢ
US4261910A (en) * 1978-08-14 1981-04-14 Kureha Kagaku Kogyo Kabushiki Kaisha Process for the preparation of Chlorambucil derivatives
GB2070597B (en) * 1980-02-15 1983-07-27 Taiho Pharmaceutical Co Ltd Sulphonium compounds
NL8001593A (nl) * 1980-03-18 1981-10-16 Akzo Nv Meerfasisch combinatiepreparaat voor orale anticonceptie.
FR2494697A1 (fr) * 1980-11-21 1982-05-28 Roussel Uclaf Nouveaux derives steroides 3-amines, leurs sels, procede et intermediaires de preparation, application a titre de medicaments et compositions les renfermant
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
GB8413191D0 (en) * 1984-05-23 1984-06-27 Beecham Group Plc Pharmaceutical composition
JPS6450919A (en) * 1987-08-21 1989-02-27 Sharp Kk Photosensing element

Also Published As

Publication number Publication date
DE3736691C2 (fr) 1991-05-23
AU8012187A (en) 1988-05-19
ATA279787A (de) 1991-02-15
IT1223323B (it) 1990-09-19
GB8725267D0 (en) 1987-12-02
GB2232353A (en) 1990-12-12
JPH0621072B2 (ja) 1994-03-23
US4885290A (en) 1989-12-05
GB2197588A (en) 1988-05-25
GB2197588B (en) 1991-03-13
JPS63122625A (ja) 1988-05-26
AT393222B (de) 1991-09-10
IT8722414A0 (it) 1987-10-27
GB9013267D0 (en) 1990-08-08
DE3736691A1 (de) 1988-05-26
GB2232353B (en) 1991-03-20
AU585179B2 (en) 1989-06-08
CH674465A5 (fr) 1990-06-15

Similar Documents

Publication Publication Date Title
Powles et al. Cyclosporin A for the treatment of graft-versus-host disease in man
US10799521B2 (en) Use of icaritin in preparing medicament for preventing or treating hematocytopenia
TW466112B (en) Novel use of 2'-deoxy-2',2'-difluorocytidine for immunosuppressive therapy and pharmaceutical composition comprising the same
JP2009520697A (ja) サイトカイン調節性を有する化合物
JPH02237922A (ja) 抗ウィルス剤
JP2016534074A5 (fr)
NL8702598A (nl) Immunoregulator die een estradiolderivaat bevat.
JPH0625059B2 (ja) 悪性腫瘍治療剤
US4157391A (en) Cholesterol derivative-based medicaments acting on bio-protective mechanisms
JPH05509309A (ja) ２―フェニル―１，２―ベンズイソセレナゾール―３（２ｈ）―オンの利用法
EP0442744A2 (fr) Traitement des maladies virales avec des glycosides
US3803319A (en) Treating hyperlipemia with isatin
EP0238198A2 (fr) Procédé de modification de la fonction de la structure lipidique et de l'expression des membranes cellulaires et compositions pharmaceutiques pour l'utilisation à cet effet
CN101190935B (zh) 用于病毒性感染的化合物
KR960015953B1 (ko) 피부에 축적하는 외용의 항바이러스성 약학적 조성물 및 그 제조방법
Das et al. Effects of monothioglycerol, alpha-chlorohydrin and 5-thio-D-glucose on the fertility of male hamster
DE10228059B4 (de) Verwendung von amphiphilen Nucleosid-Phosphonoameisensäure-Derivaten zur Behandlung von viralen Infektionskrankheiten
JPH03287531A (ja) 膵炎治療薬
CN116370471A (zh) 一种用于脑卒中的组合物
CA1073816A (fr) Medicaments a base de derives du cholesterol agissant sur les mecanismes bio-protecteurs
CN116407558A (zh) 预防和/或治疗化疗药物损伤消化道的保护剂及其应用
JPS607601B2 (ja) 医薬用カプセル基剤
Alain Thibault et al. A PHASE II STUDY OF 5-AZA-2'DEOXYCYTIDINE (DECITABINE)
JPH0640905A (ja) 免疫抑制剤
Kauffman et al. 339 SERUM CONCENTRATIONS OF 9-β-D-ARABINOFURANOSYL-HYPOXANTHINE IN INFANTS TREATED WITH VIDARABINE

Legal Events

Date Code Title Description
A1B A search report has been drawn up
BT A notification was added to the application dossier and made available to the public
BC A request for examination has been filed
BN A decision not to publish the application has become irrevocable